Dronabinol is classed for a pregnancy Classification C drug, as it hasn't exhibited teratogenic consequences in animal designs at doses ranging from 0.2 to 5 occasions the utmost advisable human dose. Having said that, it is important to notice that pregnant patients have not been subjected